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The inhibitory regulatory component of adenylate cyclase (Ni) was highly purified from rat brain synaptic 
membranes. A iow Km GTPase activity was always associated with Ni through the purification, and the 
recovery of GTPase activity correlated well with that of Nr. Purified Ni was hardly ADP-ribosyiated by 
islet-activating protein (IAP). A heat-labile factor in the fraction of the stimulative regulatory component 
(N,) restored ADP-ribosylation and also activated the GTPase about 2-fold. NaF which was reported to 
interact with Ni markedly reduced GTPase activity. The purified Nr fraction inhibited adenylate cyclase 
only in the presence of a heat-stabIe factor found in the partially purified regulatory component. GTPase 
and inhibitory activities were weak in myelin which contained only a small amount of Ni. These findings 
support the view that GTPase activity is an intrinsic activity of Nr and some factors are necessary for the 
function of Ni. 
G TPase Inhibitory regulatory component (Ni) 
ADP-ribosylation 
1. INTRODUCTION 
A variety of hormones and neurotransmitters 
activate or inhibit adenylate cyclase through their 
receptors on the cell surface. The stimulative and 
inhibitory GTP-binding regulatory components 
termed N, and Nr, respectively, have been propos- 
ed to couple these receptors and the catalytic unit 
of adenylate cyclase [l]. N, is a dimer composed of 
a GTP-binding subunit, the substrate of cholera 
toxin, and a subunit of Mr 35000 [Z]. It has been 
shown that IAP, a toxin from Bordeteilapertussis, 
attenuated the receptor-mediated inhibition of 
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adenylate cyclase probably by the ADP- 
ribosylation of a membrane protein of n/r, 41000 
[3,4]. This 41-kDa protein, considered to be Ni, 
was purified as a complex with a 35kDa protein 
[5,6j. The 41-kDa protein proved to be a guanine 
nucleotide-binding protein [5]. However, inhibi- 
tion of adenylate cyclase by the isolated Nt has not 
been demonstrated. stimulative and inhibitory 
hormones also enhance GTP hydrolysis in plasma 
membranes which may occur at the GTP-binding 
sites of these two regulatory components 17~31. 
Cholera toxin j7] and IAP 19-l 11 were reported to 
prevent the GTP hydrolysis enhanced by 
stimulative and inhibitory hormones, respectively. 
This GTPase has not been isolated from 
membranes. 
Abbreviations: IAP, islet-activating protein; Ns and Ni, In [12], we solubilized a low-& GTPase activity 
the stimulative and inhibitory GTP-binding regulatory from synaptic plasma membranes prepared from 
components of adenyIate cyciase, respectiveiy; rat brain. This GTPase was associated with the 
Gpp(NH)p, 5 ‘-guanylyl imidodiphosphate partially purified regulatory component of 
Adenylate cyclase 
Rat brain 
Islet-activating protein 
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adenylate cyclase and was suggested to be involved 
in the regulation of adenylate cyclase activity. The 
partially purified fraction of the regulatory com- 
ponent contained both N, and Ni as confirmed 
here. We therefore investigated which regulatory 
component was associated with the GTPase by 
separating N, and Ni. The GTPase activity was 
copurified with Ni, which supported our 
hypothesis that the GTPase activity is an activity 
of Ni. 
2. MATERIALS AND METHODS 
[Y-~~P]GTP and [32P]NAD were purchased from 
New England Nuclear. IAP was a generous gift 
from Dr Michio Ui (Hokkaido University, Sap- 
poro). Heptylamine-Sepharose was prepared as in 
[ 131. Sepharose CL-4B (Pharmacia) was used as a 
matrix. 
2.1. Membranes 
A synaptosome-rich membrane fraction and 
myelin were prepared from rat brain as in [14]. 
2.2. Solubilization, purification and separation of 
NS and Ni 
The synaptosome-rich membrane fraction was 
homogenized in 0.2 M sucrose, 15 mM MgC12, 
1 mM dithiothreitol, 50 mM Tris-HCI, pH 8.0 
(final concentration 27-30 mg protein/ml). The 
homogenate was mixed with 0.5 vol. of 84 mM 
sodium cholate, stirred for 1 h, and centrifuged at 
105000 x g for 1 h. The supernatant was diluted 
with 20 mM Tris-HCI (pH 8.0) to reduce the 
cholate concentration to 21 mM for chromatog- 
raphy. Further purification by DEAE-Sephacel, 
Ultrogel AcA 34 and heptylamine-Sepharose 
chromatography in the presence of cholate was 
performed as in [2] for the purification of N, from 
rabbit liver, except that ATP was replaced by 
20 pM AlC13 in all buffers [ 151. Bovine serum 
albumin (final concentration 1 mg/ml) was added 
to the fractions eluted from a heptylamine-Sepha- 
rose column to stabilize GTPase and the regulatory 
components. The fractions containing Ni and N, 
were diluted with 2-3 vols of 20 mM Tris-HCl 
(pH 8.0) and concentrated to about 10% of the 
original volume by ultrafiltration with Amicon 
PM-10 and PM-30 membranes, respectively. 
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Lubrol PX (final concentration 0.5070, w/v) was 
added to the concentrated fractions. 
2.3. Partially purified regulatory component 
In our earlier study on the adenylate cyclase 
system, we used the partially purified fraction of 
the regulatory component, which contained N, and 
Ni as confirmed here. The properties of this frac- 
tion have been studied by us [12] and in [ 161. The 
regulatory component was solubilized from the 
synaptosome-rich membrane fraction with cholate 
and ammonium sulfate and partially purified by 
Sepharose 6B chromatography to remove the 
catalytic unit as in [16]. The fraction solubilized 
from myelin was used without purification by gel 
chromatography as myelin has no catalytic unit 
[14]. These fractions were stored at - 80°C and 
used in the experiments detailed in tables 3 and 4. 
2.4. Assay of activities 
Before the assay of activities, an aliquot of col- 
umn fraction (usually 40-50~1) was diluted with 
10 vols of a buffer containing 14 mM cholate, 
7 mg/ml phospholipid and 25% saturated am- 
monium sulfate, and then mixed with 11 vols of 
saturated ammonium sulfate (pH 7.6). 
Precipitated protein was dissolved in a buffer con- 
taining 7 mg/ml phospholipid and 0.1% (w/v) 
Lubrol PX [12]. When the amount of protein was 
low, lo-20pg/tube of y-globulin was added as a 
carrier protein. This procedure was necessary to 
remove the cholate which interfered with the assay. 
GTPase activity was assayed with 2 PM GTP at 
37°C for 10 min [12]. Adenylate cyclase activity 
was reconstituted at 23°C for 3 h from N, and the 
partially purified catalytic unit (7.57pg pro- 
tein/tube) in the presence of 60pM Gpp(NH)p 
[12]. The specific activity of the catalytic unit in 
the presence of 5 mM MnC12 was 1620 pmol cyclic 
AMP - min-’ . mg protein- ‘. Inhibition of the 
catalytic unit by the partially purified regulatory 
component shown in table 4 was measured as in 
[12] except hat 1 PM forskolin was included in the 
cyclase assay. Adenylate cyclase was assayed for 
10 min at 30°C as in [17] except that GTP was 
omitted. The amount of cyclic AMP formed was 
determined by the cyclic AMP-binding protein 
assay [18]. 
The ADP-ribosylation by IAP (25 pg/ml) was 
carried out at 25°C for 30 min as in [4] except that 
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0.1 mM GTP and 5 mM nicotinamide were includ- 
ed in the medium. The reaction was stopped by the 
addition of 15% (w/v) trichloroacetic acid con- 
taining 1% (w/v) SDS. Precipitated protein was 
washed with 10% (w/v) trichloroacetic acid and 
then with diethyl ether to remove the residual 
trichloroa~etic acid. Protein was solubilized and 
subjected to SDS-PAGE as in [19]. The ADP- 
ribosylated band detected by autoradiography was 
cut out from the gel and the radioactivity was 
measured in a scintillation counter. 
3. RESULTS AND DISCUSSION 
A low-& GTPase activity was solubilized with 
cholate from synaptosome-rich membrane fraction 
prepared from rat brain. More than 90% of the 
solubilized GTPase activity was low& activity 
under the standard assay conditions. The GTPase 
was further purified by successive chromatography 
as shown in fig. 1. The activity of N, in the eluted 
fractions was assayed by the activation of the par- 
tially purified catalytic unit in the presence of 
Gpp(NH)p. The content of Ni was estimated by 
IAP-catalyzed ADP-ribosylation. GTPase, Ni and 
N, activities were eluted in the same fraction from 
a DEAE-Sephacel column (fig. la). GTPase activi- 
ty and Ni were slightly separated from N, by subse- 
quent Ultrogel AcA 34 chromatography (fig.lb). 
Peak fractions of GTPase and Ni were collected 
and then subjected to heptylamine-Sepharose 
chromatography (fig.lc). GTPase activity was 
nearly completely separated from N, by this 
chromatography, but only a small amount of Ni 
was recovered in the eluted fractions. 
Autoradiographs of the protein [32P]ADP- 
ribosylated by IAP showed that most of the Ni was 
present in the GTPase fraction (fig. lc). Authors in 
[20] purified Ni from rabbit liver by a similar pro- 
cedure although they did not mention GTPase ac- 
tivity and the poor recovery of Ni from a 
heptylamine-Sepharose column. Our fraction 
containing N, and GTPase is probably similar to 
their fraction of Ni. The fraction containing Ni and 
GTPase activity is hereafter designated as the ‘Ni- 
GTPase fraction’. 
The recovery of GTPase activity in the purifica- 
tion was very different from that of N, but similar 
to that of Ni during the first two steps of 
chromatography (table 1). However, the recovery 
Fraction number 
Fraction number 
Fig.1. Co-purification of GTPase activity with Ni. The 
cholate extract (usually 140-W mg protein) from a 
synaptosome-rich membrane fraction was subjected to 
DEAE-Sephacel chromatography (1.6 x 18 cm, 
2 ml/fraction) (a). Fractions 77-95 were collected and 
further purified by Ultrogel AcA ,34 chromatography 
(1.6 x 36 cm, 1.3 ml/fraction) (b). Fractions 40-49 
from an Ultrogel column were collected and applied to 
a heptylamine-Sepharose column (1 .O x I.5 cm, 1.2 ml/ 
fraction) (c). The autoradiographs in panel c show 
the 41-kDa protein that was [32P]ADP-ribosylated by 
IAP. Ni content (0) was estimated by IAP-catalyzed 
ADP-ribosylation. N, activity (A) was assayed by 
reconstitution of adenylate cyclase activity with the 
‘partially purified catalytic unit. GTPase activity (0) was 
assayed as described in section 2. (- - -) Absorbance at 
280 nm. Elution by a linear gradient was started at the 
point indicated by the arrow. 
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Table 1 
Comparison of the recoveries of GTPase activity, Ni and N, 
Step Low-Km GTPase 
activity 
(nmol Pi/min) 
ADP-ribosyl residue Activity for 
incorporated reconstitution of 
(Ni content) adenylate cyclase 
(nmol) (N, activity) 
(nmol cyclic AMP/min) 
Cholate extract 11.2 5.06 115 
DEAE-Sephacel 5.90 2.24 24.9 
Ultrogel AcA 34 4.80 2.62 19.4 
Heptylamine-Sepharose 
Nr-GTPase fraction 0.85 0.01 not detected 
N, fraction 0.06 trace 31.1 
The cholate extract (141 mg protein) from the synaptosome-rich membrane fraction was subjected to 
chromatography as described in fig. 1. The recovery of Ni was estimated by IAP-catalyzed ADP- 
ribosylation and N, activity was determined by reconstitution of adenylate cyclase activity with the 
partially purified catalytic unit. The fraction from a heptylamine-Sepharose column which contained both 
Ni and GTPase activity was designated as the Ni-GTPase fraction 
of Ni from a heptylamine-Sepharose column was 
quite low compared with that of GTPase activity. 
We supposed that this apparently poor recovery of 
Ni could be ascribed to insufficient ADP- 
ribosylation but not to a true deficiency of Ni in 
the Ni-GTPase fraction. We found that the activity 
which markedly enhanced ADP-ribosylation was 
actually present in the NS fraction eluted from a 
heptylamine-Sepharose column. As shown in 
table 2, efficient ADP-ribosylation in the Ni- 
GTPase fraction was restored when combined with 
the concentrated N, fraction. Thus we could 
estimate the actual recovery of Ni in the Ni- 
GTPase fraction as 0.8-l .3 nmol, which was com- 
parable to the recovery of GTPase activity. We 
also found that GTPase was activated about 2-fold 
by addition of the N, fraction (table 2). These ac- 
tivities which enhanced ADP-ribosylation and 
GTPase activity were heat-labile. The activity to 
stimulate ADP-ribosylation decreased con- 
siderably during storage at - 8O”C, at which 
temperature GTPase and N, activities were fairly 
stable. Authors in [20] reported that their fraction 
of Ni similar to our Ni-GTPase fraction lacked the 
35kDa protein usually associated with the 41-kDa 
protein of Ni. Therefore, the 35kDa protein may 
possibly be the necessary factor for ADP- 
ribosvlation and activation of GTPase. 
to 29 and 11% of the control, respectively, as 
reported for GTPase in synaptic plasma mem- 
branes [ 121. F- was reported to induce dissociation 
of the 41-kDa and 35-kDa proteins of Ni [5]. NaCl 
at 100 mM slightly enhanced GTPase activity to 
112-l 18% of the control. Trypsin (30 pglml) and 
rY-chymotrypsin (300 pg/ml) nearly completely in- 
activated GTPase. ADP-ribosylation of Ni did not 
Table 2 
Effects of the Ns fraction on ADP-ribosylation of Ni by 
IAP and GTPase activity 
Fraction ADP-ribosylation GTPase activity 
(pm01 ADP- (pm01 Pi/min 
ribosyl per ml) 
residue/ml) 
Ni-GTPase 32 654 
N, 25 100 
Ni-GTPase + N, 510” 1390= 
a The activity/m1 of the Nr-GTPase fraction is shown 
The concentrated Ni-GTPase and N, fractions from a 
heptylamine-Sepharose column and the mixture of 
equal volumes of these fractions were preincubated at 
23’C for 30 min. Aliquots were used for ADP- 
ribosylation and assay of GTPase activity. The Ns 
activity in the N, fraction was 14.4 nmol cyclic 
NaF at 10 and 30 mM reduced GTPase activity AMP/min per ml 
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affect GTPase activity. IAP was reported to pre- 
vent inhibitory hormones from enhancing GTPase 
activity in membranes [9-l 11, but it is not known 
whether unstimulated basal GTPase activity 
related to the function of Ni is also inhibited by 
IAP. 
We previously found that the partially purified 
fraction of the regulatory component from synap- 
tic plasma membranes inhibited the activity of the 
catalytic unit of adenylate cyclase [12]. This was 
confirmed here (see table 4). This inhibitory activi- 
ty was supposed to be the activity of Ni. Contrary 
to our expectations, the Ni-GTPase fraction failed 
to inhibit adenylate cyclase under various condi- 
tions. We considered that the failure was due to the 
lack of a necessary factor which was lost during the 
purification. To examine this possibility, we 
employed the partially purified fraction of the 
regulatory component containing both N, and Ni 
(see table 4) as a source of the putative cofactor. 
The catalytic unit of adenylate cyclase was ac- 
tivated in the presence of excess purified N, and 
Gpp(NH)p for the assay of inhibition. The addi- 
tion of the Ni-GTPase fraction to the activation 
medium did not inhibit the cyclase. However, the 
Ni-GTPase fraction added to the partially purified 
fraction of the regulatory component considerably 
reduced cyclase activity. Inclusion of the partially 
purified fraction in the activation medium partly 
inhibited the cyclase probably due to the Ni present 
in this fraction. The extent of inhibition by the Ni- 
GTPase fraction depended on the amount of par- 
tially purified fraction added. The partially 
purified fraction heated in boiling water did not in- 
hibit cyclase activity by itself but still supported in- 
hibition of cyclase by the Ni-GTPase fraction 
(table 3, exp.2). These results indicate that a cer- 
tain heat-stable factor, in addition to Nr, is re- 
quired for the inhibition of adenylate cyclase. 
The 35kDa protein was reported to inhibit or 
attenuate the activation of N, by guanine 
nucleotides and F- [20]. However, it is unlikely 
that the inhibition of adenylate cyclase shown in 
table 3 was induced by the 35kDa protein released 
from Ni, since the Ni-GTPase fraction probably 
lacked the 35kDa protein. Ni seems to inhibit the 
cyclase by interacting directly with the catalytic 
unit. Ni may replace N, on the catalytic unit or 
Table 3 
Requirement for a cofactor in the inhibition of adenylate cyclase by Ni-GTPase fraction 
Partially purified 
regulatory component 
(cofactor fraction) 
(clg protein) 
Adenylate cyclase activity 
(pmol cyclic AMP/IO min) 
- Ni-GTPase + Ni-GTPase 
Decrease of adenylate 
cyclase activity by 
Nr-GTPase fraction 
(pmol cyclic AMP/IO min) 
Exp. 1 
0 
31 
62 
109 99.7 9.3 
78.2 59.1 19.1 
71.2 43.3 27.9 
Exp.2 
0 
46 
46 (heated) 
77.4 90.3 - 12.9 
54.0 39.1 14.9 
83.0 55.7 27.3 
Partially purified catalytic unit (7.57 pg protein) was activated at 23°C for 3 h by purified N, 
(18 pmol cyclic AMP/min per tube) and 60 pM Gpp(NH)p. For assay of inhibition, the activation 
medium included the Ni-GTPase fraction (GTPase activity; 5.45 pmol Pr/min per tube) from a 
heptylamine-Sepharose column and the indicated amounts of the regulatory component partially 
purified from a synaptosome-rich membrane fraction as described in section 2. The partially 
purified fraction of the regulatory component contained a cofactor for the inhibition in addition 
to N, and Nr (see also table 4). In exp.2, the partially purified regulatory component was heated 
for 5 min in boiling water. Adenylate cyclase was assayed at 30°C for 10 min 
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Table 4 
Content of Ni and related activities in myelin 
Source of the 
partially purified 
regulatory component 
Activity for GTPase activity ADP-ribosylation Inhibition of 
reconstitution of (pm01 Pi/min per mg) by IAP adenylate cyclase 
adenylate cyclase (Nr content) activity of the 
(N, activity) (pmol ADP-ribosyl catalytic unit 
(pm01 cyclic residue/mg) (olo inhibition) 
AMP/min per mg) 
Myelin 142 11 2.9 6 
Synaptic membranes 203 138 32 38 
Partially purified regulatory component was prepared from myelin and a synaptosome-rich membrane fraction as 
described in section 2. N, activity was determined by reconstitution of adenylate cyclase activity, and Ni content was 
estimated by IAP-catalyzed ADP-ribosylation. Inhibition of activity of the catalytic unit by the regulatory component 
(16.2 pg protein/tube) was assayed at 30°C for 10 min in the presence of 1 FM forskolin. The activity of the catalytic 
unit in the absence of the regulatory component was 105 pmol cyclic AMP/10 min per tube 
bind to a different site on the catalytic unit. The 
latter possibility is more likely because further ad- 
dition of purified N, to the activation medium did 
not greatly prevent inhibition by the Ni-GTPase 
fraction. 
We reported that myelin had very weak GTPase 
activity despite the N, activity which was com- 
parable to that in synaptic plasma membranes 
[12,14]. The weak GTPase activity correlated well 
with the low content of Ni in myelin (table 4). The 
activity to inhibit the catalytic unit was found to be 
weak in the fraction from myelin (table 4). If 
myelin is assumed to have abundant factors for the 
activities of Ni, the Ni content in the fraction from 
myelin is much lower than that in the fraction from 
synaptic membranes. The very different ratio bet- 
ween N, and Ni in the two fractions of the 
regulatory component suggests that N, and Ni exist 
independently, rather than forming a bimolecular 
complex. 
The present study strongly indicates that the 
low-K,,, GTPase solubilized from rat brain 
synaptosome-rich membrane fraction is an integral 
part of Ni. GTPase may be the 41-kDa protein of 
Ni itself, or else the 41-kDa protein and other pro- 
teins may be required for GTPase activity. We 
previously found that a low-K,,, GTPase activity in 
synaptic plasma membranes was somewhat in- 
hibited by cholera toxin [12], but we have not 
found GTPase activity associated with the purified 
N,. The GTPase activity considered to be related to 
N, may be lost during solubilization. 
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It is an intriguing question as to whether the 
isolated 41-kDa protein of Ni indeed inhibits 
adenylate cyclase. Here, we showed that the Ni- 
GTPase fraction actually suppressed adenylate 
cyclase activity with dependence of a certain heat- 
stable factor. However, the precise mechanism of 
inhibition and the identification of the heat-stable 
factor remain to be elucidated. 
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